Self Efficacy, Walking Ability, Gait Speed and Physical Activity in People With Chronic Lung Disease

Completed

Conditions studied: Chronic Lung Disease, Self-efficacy

In brief

Most patients with chronic lung disease underestimate their actual walking ability due to low confidence. To better understand the relationships between lung function, self-efficacy for walking (confidence in ability to walk a defined distance), actual walking ability for the same distance gait speed and physical activity level-PAL- (total energy expenditure/resting metabolic rate). Quality of life, self efficacy for activity questionnaires, physical activity level measurement, 4-meter gait speed and 6-minute walk distance will be measured.

Key facts

Study ID

NCT01583595

Run by

Mayo Clinic

People needed

70

Starts

2011-12-01

Expected to finish

2012-07-01

Last updated by the study team

2013-04-04

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men and women 40 years and older
• Diagnosis of any chronic lung disease as evidenced by pulmonary function testing completed within the prior 12 months
• Able to walk independently and successfully complete the 6-minute walk assessment

You may not qualify if…

• Unable to walk without assistance or complete the 6-minute walk assessment
• Patients unable to comprehend and accurately respond to the study questionnaires either by written or spoken communication
• Patients diagnosed with or treated for a lower respiratory tract infection or COPD exacerbation within the prior 30 days

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.